Sirianong Namwongprom

Sirianong Namwongprom

Auto-generated profile, based on publicly available information

Sirianong Namwongprom

Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2015 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
KMKathleen Mulligan
Kathleen Mulligan
DGDavid V. Glidden
David V. Glidden
PAPeter L. Anderson
Peter L. Anderson
ALAlbert Liu
Albert Liu
VMVanessa McMahan
Vanessa McMahan
JRJames Rooney
James Rooney
Background. Daily preexposure prophylaxis (PrEP) with oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) decreases the risk of human immunodeficiency virus (HIV) acquisition. Initiation of TDF decreases bone mineral density (BMD) in HIV-infected people. We report the effect of FTC/TDF on BMD in HIV-seronegative men who have sex with men and in transgender women. Methods. Dual-energy X-ray absorptiometry was performed at baseline and 24-week intervals in a substudy of iPrEx, a randomized, double-blind, placebo-controlled trial of FTC/TDF PrEP. Plasma and intracellular tenofovir concentrations were measured in participants randomized to FTC/TDF. Results. In 498 participants (247 FTC/TDF, 251 placebo), BMD in those randomized to FTC/TDF decreased modestly but statistically significantly by 24 weeks in the spine (net difference, −0.91% [95% confidence interval {CI}, −1.44% to −.38%]; P = .001) and hip (−0.61% [95% CI, −.96% to −.27%], P = .001). Changes within each subsequent 24-week interval were not statistically significant. Changes in BMD by week 24 correlated inversely with intracellular tenofovir diphosphate (TFV-DP), which was detected in 53% of those randomized to FTC/TDF. Net BMD loss by week 24 in participants with TFV-DP levels indicative of consistent dosing averaged −1.42% ± 29% and −0.85% ± 19% in the spine and hip, respectively (P < .001 vs placebo). Spine BMD tended to rebound following discontinuation of FTC/TDF. There were no differences in fractures (P = .62) or incidence of low BMD. Conclusions. In HIV-uninfected persons, FTC/TDF PrEP was associated with small but statistically significant decreases in BMD by week 24 that inversely correlated with TFV-DP, with more stable BMD thereafter. Clinical Trials Registration. NCT00458393.

31 July 2014 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
PVPataramon Vasavid
Pataramon Vasavid
TCTawatchai Chaiwatanarat
Tawatchai Chaiwatanarat
PPPawana Pusuwan
Pawana Pusuwan
CSChanika Sritara
Chanika Sritara
KRKrisana Roysri
Krisana Roysri
SGSutep Gonlachanvit
Sutep Gonlachanvit
Pataramon Vasavid, Tawatchai Chaiwatanarat, Pawana Pusuwan, Chanika Sritara, Krisana Roysri, Sirianong Namwongprom, Pichit Kuanrakcharoen, Teerapon Premprabha, Kitti Chunlertrith, Satawat Thongsawat, Siam Sirinthornpunya, Bancha Ovartlarnporn, Udom Kachintorn, Somchai Leelakusolvong, Chomsri Kositchaiwat, Suriya Chakkaphak, and Sutep Gonlachanvit. J Neurogastroenterol Motil 2014;20:371-8. http://dx.doi.org/10.5056/jnm13114

12 November 2013 in ISRN Pediatrics
Verified
Journal Article
Open access
PDF file
SPSurangrat Pongpan
Surangrat Pongpan
AWApichart Wisitwong
Apichart Wisitwong
CTChamaiporn Tawichasri
Chamaiporn Tawichasri
JPJayanton Patumanond
Jayanton Patumanond
SNSirianong Namwongprom
Sirianong Namwongprom
Objectives. To develop a simple scoring system to predict dengue infection severity based on patient characteristics and routine clinical profiles. Methods. Retrospective data of children with dengue infection from 3 general hospitals in Thailand were reviewed. Dengue infection was categorized into 3 severity levels: dengue infection (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). Coefficients of significant predictors of disease severity under ordinal regression analysis were transformed into item scores. Total scores were used to classify patients into 3 severity levels. Results. Significant clinical predictors of dengue infection severity were age >6 years, hepatomegaly, hematocrit ≥40%, systolic pressure 5000 /μL, and platelet ≤50000 /μL. The derived total scores, which ranged from 0 to 18, classified patients into 3 severity levels: DF (scores 11.5, n=50, 6.4%). The derived score correctly classified patients into their original severity levels in 60.7%. An under-estimation of 25.7% and an over-estimation of 13.5% were clinically acceptable. Conclusions. The derived dengue infection severity score classified patients into DF, DHF, or DSS, correctly into their original severity levels. Validation of the score should be reconfirmed before application of routine practice.

1 January 2015 in Forensic Science International
Verified
Journal Article
Closed access
NPNuttaya Pattamapaspong
Nuttaya Pattamapaspong
CMChakri Madla
Chakri Madla
KMKarnda Mekjaidee
Karnda Mekjaidee
SNSirianong Namwongprom
Sirianong Namwongprom

30 March 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Linda AurpibulLinda Aurpibul
Linda Aurpibul
SNSirianong Namwongprom
Sirianong Namwongprom
TSTavitiya Sudjaritruk
Tavitiya Sudjaritruk
SOSakaewan Ounjaijean
Sakaewan Ounjaijean
People living with HIV who are on antiretroviral treatment are at increased risk of developing premature cardiovascular disease. Children with perinatal HIV infection (PHIV) have survived through their adolescence and are entering adulthood. We determined the prevalence of metabolic syndrome, abnormal biochemical markers, and characterized body composition parameters in youth living with perinatal HIV infection. This cross-sectional study was conducted at the Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand from December 2017 to February 2018. PHIV-youths between 15 <25 years of age who were receiving ART were enrolled. Data collection included ART-related history, blood pressure, and anthropometric measurements. Body composition including android, gynoid fat mass, and total body fat were measured by dual-energy X-ray absorptiometry. Fasting blood was drawn to test for lipid profile, glucose, and high sensitivity c-reactive protein (hsCRP). One hundred and twenty PHIV-youths (48% female) were enrolled. Their mean age and the median duration on ART were 20.3 (SD2.6) and 14.1 (IQR 10.4–14.9) years, respectively; 76 (63%) were on first-line non-nucleoside reverse transcriptase inhibitors-based regimens. Thirty-three (28%), 74 (62%), and 13 (11%) of PHIV-youths were underweight (BMI < 18.5 kg/m2), normal (BMI 18.5–24.9 kg/m2), and overweight (BMI ≥ 25.0 kg/m2), respectively. The prevalence of metabolic syndrome was 10.6% (95%CI 5.0–16.0). Seventy-six of 113 (67.3%) of PHIV-youths had lipid alteration; the most prevalent types being low HDL (46.9%) and increased triglycerides (27.4%). Overall 43 (35.9%) had increased hsCRP (16.7% with immediate and 19.2% with high risk for CVD). Females had significantly higher percentage of android and gynoid fat, but lower Android to gynoid ratio (AGR) compared to males. There were 77%, 31%, and 21% of PHIV-youths in the overweight, normal weight, and underweight group with AGR in tertile 3, respectively. In conclusion, we documented presence of metabolic syndrome in 10.6% of PHIV-youths on ART. Increase AGR representing abdominal obesity was detected even in youths with normal BMI or underweight.

1 May 2008 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
SNSirianong Namwongprom
Sirianong Namwongprom
FWFranklin C. Wong
Franklin C. Wong
UTUkihide Tateishi
Ukihide Tateishi
EKEdmund E. Kim
Edmund E. Kim
SBSombut Boonyaprapa
Sombut Boonyaprapa